基本信息
浏览量:20
职业迁徙
个人简介
Dr. Ariel E. Marciscano is a board-certified radiation oncologist and Assistant Professor of Radiation Oncology at Weill Cornell Medicine/New York Presbyterian Hospital. He is a New York/New Jersey native. He received his undergraduate degree in Biology at Georgetown University where he was a Howard Hughes Medical Institute (HHMI) undegraduate research scholar. He received his M.D. from New York University School of Medicine during which time he studied radiosensitization of glioma via TGFbeta blockade in the Barcellos-Hoff laboratory. He completed a medical internship at Massachusetts General Hospital and residency training in radiation oncology at The Johns Hopkins Hospital. During his time at Johns Hopkins, Dr. Marciscano studied mechanisms of synergy of radiation and immunotherapy in the Bloomberg-Kimmel Institute for Cancer Immunotherapy in the laboratory of Charles G. Drake and subsequently completed a fellowship in Immunotherapy at the NCI, Center for Cancer Research. Dr. Marciscano joined the faculty at Memorial Sloan Kettering focusing on genitourinary cancers and metastatic disease with research initiatives in combining stereotactic radiation with immunotherapy for patients with metastatic cancer and developing novels methods to non-invasively treat and monitor response to stereotactic radiation. He has published several peer-reviewed manuscripts, review articles and book chapters and regularly presents his research at national and international scientific meetings.
Dr. Marciscano is currently a faculty member at Weill Cornell Medicine as Assistant Professor of Radiation Oncology. In his current role, he serves as Director of Radiation Therapy Preclinical Core (RTPC) and runs a research laboratory focusing on optimizing radiation-immunotherapy synergy, novel radiation-drug combinations and understanding the immune response to stereotactic radiation within the tumor microenvironment. He is also a member of the Radiation Oncology Clinical Research Office (ROCRO) providing a link between preclinical and clinical initiatives within the Department of Radiation Oncology.
Dr. Marciscano is currently a faculty member at Weill Cornell Medicine as Assistant Professor of Radiation Oncology. In his current role, he serves as Director of Radiation Therapy Preclinical Core (RTPC) and runs a research laboratory focusing on optimizing radiation-immunotherapy synergy, novel radiation-drug combinations and understanding the immune response to stereotactic radiation within the tumor microenvironment. He is also a member of the Radiation Oncology Clinical Research Office (ROCRO) providing a link between preclinical and clinical initiatives within the Department of Radiation Oncology.
研究兴趣
论文共 86 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
M. Diven, A. Hakansson,Y. Liu,E. Davicioni, A. Dillard,F. Khani, S. Wolfe,J. C. Hu, D. S. Scherr,T. D. McClure, C. E. Barbieri, H. Nagar,
International journal of radiation oncology, biology, physicsno. 2 (2023): E377-E377
引用0浏览0引用
0
0
Sydney Wolfe, Marshall A. Diven,Ariel E. Marciscano,Xi Kathy Zhou, A. U. Kishan, M. L. Steinberg,Joseph A. Miccio,Philip Camilleri,Himanshu Nagar
BMC cancerno. 1 (2023): 1-11
引用0浏览0引用
0
0
IOP Publishing eBookspp.3-17, (2023)
引用0浏览0引用
0
0
Journal of Clinical Oncologyno. 6_suppl (2023): TPS400-TPS400
引用0浏览0引用
0
0
Sarah A Qureshy, Marshall A Diven,Xiaoyue Ma,Ariel E Marciscano,Jim C Hu, Tim D McClure,Christopher Barbieri,Himanshu Nagar
JAMA network openno. 10 (2023)
引用0浏览0WOS引用
0
0
Oncoimmunologyno. 1 (2023): 2222560
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn